<DOC>
	<DOCNO>NCT00306176</DOCNO>
	<brief_summary>The aim present study investigate influence systemic exercise , rosiglitazone administration combine pharmaceutical lifestyle intervention cardiovascular risk factor</brief_summary>
	<brief_title>Rosiglitazone Exercise Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Type II diabetes mellitus Poor glycemic control Heart failure Renal disease Liver disease Cardiovascular event</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>rosiglitazone , exercise , cardiovascular risk factor</keyword>
</DOC>